Intratio
Loading...
Skip to main content
Model output · Signal date Oct. 14, 2026

Daily SignalsNeutral

2489 companies scored · 2026-10-14 run in progress: 1697 of ~5379 signals so far · Alpha · vs marketSwitch to Total · 30D 90D

Signal date 2026-10-14 Cut-offs from the 2026-10-13 run
Companies scored 2489 IC ≥ 0 · market cap ≥ $100M
Median forecast +0.26% Alpha · 90D
Long–short spread +3.94% Strong Buy minus Strong Sell, mean
Median IC 0.29 Spearman · 90D
Rating changes ▲ 50 ▼ 54 vs the previous run
Cross-section

Distribution of the day's forecasts

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Signals · Neutral

71 companies

Sorted by 90D forecast ↓

# Ticker Sector IC Mkt cap Rating 30D 90D Δ
51 AGLagilon health, inc. Industrial Applications and Services 0.49 $1.4B Neutral -0.14% -0.26% ·
52 KVUEKenvue Inc. Industrial Applications and Services 0.03 $34.1B Neutral -0.10% -0.26% ·
53 NWLNEWELL BRANDS INC. Industrial Applications and Services 0.57 $2.4B Neutral -0.10% -0.30% ·
54 DXCMDEXCOM INC Industrial Applications and Services 0.19 $32.4B Neutral -0.11% -0.32% ·
55 ENOVEnovis CORP Industrial Applications and Services 0.02 $1.1B Neutral -0.04% -0.32% ▲ 1
56 BTSGBrightSpring Health Services, Inc. Industrial Applications and Services 0.50 $12.4B Neutral -0.17% -0.33% ·
57 HUNHuntsman CORP Industrial Applications and Services 0.29 $1.4B Neutral -0.19% -0.37% ·
58 NHCNATIONAL HEALTHCARE CORP Industrial Applications and Services 0.06 $3.6B Neutral -0.35% -0.37% ·
59 ATRAPTARGROUP, INC. Industrial Applications and Services 0.24 $7.6B Neutral -0.11% -0.40% ·
60 MDLNMedline Inc. Industrial Applications and Services 0.33 $46.9B Neutral -0.10% -0.40% ·
61 OLNOLIN Corp Industrial Applications and Services 0.48 $1.7B Neutral +0.23% -0.40% ·
62 ENSGENSIGN GROUP, INC Industrial Applications and Services 0.36 $10.1B Neutral +0.16% -0.41% ·
63 SCLSTEPAN CO Industrial Applications and Services 0.41 $1.4B Neutral -0.18% -0.41% ·
64 STAASTAAR SURGICAL CO Industrial Applications and Services 0.33 $1.1B Neutral -0.10% -0.41% ·
65 BLFSBIOLIFE SOLUTIONS INC Industrial Applications and Services 0.60 $1.9B Neutral +0.17% -0.42% ·
66 USPHU S PHYSICAL THERAPY INC /NV Industrial Applications and Services 0.47 $1.3B Neutral -0.10% -0.42% ·
67 ELMDElectromed, Inc. Industrial Applications and Services 0.40 $232M Neutral -0.11% -0.45% ·
68 NGVTIngevity Corp Industrial Applications and Services 0.31 $2.4B Neutral -0.11% -0.45% ·
69 BAXBAXTER INTERNATIONAL INC Industrial Applications and Services 0.55 $12.9B Neutral -0.10% -0.47% ·
70 CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. Industrial Applications and Services 0.47 $14.3B Neutral +0.21% -0.48% ·
71 MLABMESA LABORATORIES INC /CO/ Industrial Applications and Services 0.46 $714M Neutral -0.10% -0.50% ▲ 1
51–71 of 71 Previous Next
Since the previous run

Rating changes

▲ 50▼ 54
Which companies were upgraded or downgraded is part of the paid plans.
Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account
Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-13) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.